DMT-2′O-MOE-rMeC(bz) Phosphoramidite

biological source

non-animal source (no BSE/TSE risk)

product line

Proligo Reagents

assay

≥99% (³¹P-NMR), ≥99.0% (reversed phase HPLC)

form

powder

impurities

≤0.1% single unspecified Impurity (reversed phase HPLC), ≤0.3 wt. % water content (Karl Fischer), ≤0.5% CET-H-Phosphonate (reversed phase HPLC), ≤0.5% DIPA-H-Phosphonate (reversed phase HPLC), ≤0.5% DMT-rMeC(bz)moe (reversed phase HPLC), ≤0.5% DMT-rMeC(bz)moe -amidate (reversed phase HPLC), ≤0.5% DMT-rMeC(bz)moe-Bz (reversed phase HPLC), ≤0.5% H-Phosphonat (reversed phase HPLC), ≤0.5% O3, O5-Bis-DMT-rMeC(bz)moe (reversed phase HPLC), ≤0.5% P(III) 100-169ppm (³¹P-NMR), ≤3 wt. % residual solvent content

color

white to off-white

λ

conforms (UV/VIS Identity)

suitability

conforms to structure for H-NMR, conforms to structure for LC-MS

storage temp.

−20°C

Quality Level

300